G MEDICAL INNOVATION HOLDING (GMVD) Forecast, Price Target & Analyst Ratings
NASDAQ:GMVD • KYG394621414
0.181 USD
0 (0%)
At close: Aug 23, 2023
0.154 USD
-0.03 (-14.92%)
After Hours: 8/23/2023, 8:23:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for G MEDICAL INNOVATION HOLDING (GMVD).
Forecast Snapshot
Consensus Price Target
$4.08
+ 2,154.14% Upside
Next Earnings Forecast
Release DateN/A
PeriodQ4 / 2021
EPS Estimate-$13.92
Revenue Estimate
ChartMill Buy Consensus
82.86%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$4.08
Upside
+ 2,154.14%
From current price of $0.18 to mean target of $4.08, Based on 7 analyst forecasts
Low
$4.04
Median
$4.08
High
$4.20
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
7 analysts have analysed GMVD and the average price target is 4.08 USD. This implies a price increase of 2154.14% is expected in the next year compared to the current price of 0.181.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
GMVD was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about GMVD.
In the previous month the buy percentage consensus was at a similar level.
GMVD was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-06-20 | ThinkEquity | Initiate | Buy |
| 2022-01-18 | EF Hutton | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateN/A
PeriodQ4 / 2021
EPS Estimate-$13.92
Revenue EstimateN/A
Revenue Q2QN/A
EPS Q2QN/A
Number of Analysts3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2017 | 2018 | 2019 | 2021 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 109K | 3.062M 2,709.17% | 5.526M 80.47% | N/A | 13.447M | 35.19M 161.69% | |
| EBITDA YoY % growth | -26.299M -894.29% | -14.086M 46.44% | -9.909M 29.65% | N/A | N/A | N/A | |
| EBIT YoY % growth | -26.521M -896.28% | -17.184M 35.21% | -12.779M 25.63% | N/A | -7.681M | 255K 103.32% | |
| Operating Margin | -24,331.19% | -561.20% | -231.25% | N/A | -57.12% | 0.72% | |
| EPS YoY % growth | N/A | N/A | N/A | -46.41 | -0.65 | 0.06 109.38% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 21 | |
|---|---|
| EPS Q2Q % growth | -13.92 |
| Revenue Q2Q % growth | N/A |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
G MEDICAL INNOVATION HOLDING / GMVD Forecast FAQ
What do analysts expect the price target to be for G MEDICAL INNOVATION HOLDING (GMVD)?
7 analysts have analysed GMVD and the average price target is 4.08 USD. This implies a price increase of 2154.14% is expected in the next year compared to the current price of 0.181.